We've got news for you.

Register on Sunday Times at no cost to receive newsletters, read exclusive articles & more.
Register now

A Prozac a day keeps Covid-19 deaths at bay, says study


A Prozac a day keeps Covid-19 deaths at bay, says study

Experts say the finding raises the prospect of using antidepressants to treat the disease, but some are reluctant

Irina Anghel

A common antidepressant appears to reduce the risk of death in patients admitted to hospital with severe Covid-19, according to a study published in the US Medical Association’s JAMA Network Open journal.

About 9.8% of the 470 Covid-19 patients in the study who were taking fluoxetine, also sold under the brand name Prozac, died. That’s compared to more than 13% of patients with similar characteristics not receiving any antidepressants. 

A recent trial in Brazil showed fluvoxamine, another antidepressant, may reduce the risk that a patient with Covid-19 ends up in hospital. The antidepressant was chosen to be studied as a potential treatment for Covid-19 due to its anti-inflammatory properties. ..

This article is reserved for Sunday Times Daily subscribers.
A subscription gives you full digital access to all Sunday Times Daily content.

Sunday Times Daily

Already subscribed? Simply sign in below.

Questions or problems?
Email helpdesk@timeslive.co.za or call 0860 52 52 00.

Next Article